IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial).
Nadia de GruilStefan BöhringerStefanie de GrootHanno PijlJudith R KroepJesse Joachim SwenPublished in: Cancers (2023)
variants rs3743259 and rs3743258 are negatively associated with pathological response in this cohort, suggesting potential relevance as a predictive biomarker. Further research is needed to validate these findings and elucidate the underlying mechanisms and interaction with FMD.
Keyphrases
- neoadjuvant chemotherapy
- copy number
- locally advanced
- lymph node
- type diabetes
- sentinel lymph node
- physical activity
- clinical trial
- weight loss
- insulin resistance
- blood glucose
- phase iii
- randomized controlled trial
- squamous cell carcinoma
- early stage
- gene expression
- risk assessment
- pi k akt
- glycemic control
- blood pressure
- signaling pathway
- young adults
- human health